Navigation Links
Second most common infection in the US proving harder to treat with current antibiotics
Date:11/13/2012

w your state's antibiotic use compares at ResistanceMap.

"While nationally, people are starting to use antibiotics more judiciously, the new findings also show the message might not be reaching everyone. People continue to consume antibiotics at much higher rates in certain parts of the country, and the problem appears to be getting worse," said Laxminarayan. "We're hoping public health officials and health care leaders will be able to use ResistanceMap and the Drug Resistance Index to better target their education efforts to reduce inappropriate use."

High antibiotic use rates could reflect cultural norms in certain regions where consumers demand antibiotics and physicians prescribe them even when they aren't needed. Patients in remote areas may desire antibiotics for a cold or the flu, viruses which can't be treated with an antibiotic, because they have infrequent access to their doctor and want to make sure they get a "cure" on their visit. However, additional research must be done to better understand the driving factors behind antibiotic use.

Other National Findings

Other noteworthy findings from ResistanceMap included:

  • In contrast to the difficulty in treating UTIs, our ability to treat skin infections, another common reason for outpatient visits, has improved since the peak of drug-resistant infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the mid 2000s. At its height, MRSA caused 19,000 deaths a year, but infection rates have declined due to increased awareness and research efforts directed at new therapies and interventions. The new findings underscore the need to refocus the attention of drug developers and policymakers on certain species of drug-resistant organisms, such as the ones analyzed in the study, called Gram-negative bacteria.
  • National use of fluoroquinolones an antibiotic class commonly used to treat respiratory infections such as pneumonia in
    '/>"/>

Contact: Dionne Dougall-Bass
dionne@burnesscommunications.com
301-961-5803
Burness Communications
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Second-generation drug used for hypertension aids heart function independent of blood pressure
2. Second Middle East & Africa Osteoporosis Meeting to take place in Jordan
3. U-M forecasters predict second-smallest Gulf of Mexico dead zone
4. NOAA plankton surveys, second longest in the North Atlantic, add to new global effort
5. Aware, Inc. Reports Second Quarter 2012 Financial Results
6. Evermedia Group Announces 375% Increase in Revenue for Second Quarter 2012
7. Dinosaur die-out might have been second of 2 closely timed extinctions
8. Nanoengineers can print 3D microstructures in mere seconds
9. Commonly used herbicides seen as threat to endangered butterflies
10. Common North American frog identified as carrier of deadly amphibian disease
11. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2015)... OXFORD, Conn. , Apr. 6, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/143028 for ... CLOSE-PROXIMITY COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces ... wireless payments. This patent surrounds the use of ...
(Date:4/2/2015)... 2015 According to preliminary estimates ... somewhat higher than 125 MSEK. This exceeds the guidance ... that revenues for Q1 2015 would be in line ... Q4 2014. The operating result for the first quarter ... interim report will as previously communicated be published on ...
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... German . To further enhance ... Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new ... DFG,s relevant Grants Committee in Bonn. The new Research ... training at a highly specialised level within a structured ...
... can incite the body to attack its own nerve ... both viral and nerve proteins. The dual-receptor observation suggests ... be triggered in susceptible young adults afflicted with multiple ... Immunology scientists Qingyong "John" Ji, Antoine Perchellet, and Joan ...
... University of Illinois at Chicago have discovered that an ... down and inhibiting the formation of excess scar tissue ... this week in Nature Cell Biology . ... "recruited" to the wound site that rapidly produce extracellular ...
Cached Biology News:DFG establishes 12 new research training groups 2DFG establishes 12 new research training groups 3DFG establishes 12 new research training groups 4DFG establishes 12 new research training groups 5DFG establishes 12 new research training groups 6Virus infection may trigger unusual immune cells to attack nerves in multiple sclerosis 2Virus infection may trigger unusual immune cells to attack nerves in multiple sclerosis 3Virus infection may trigger unusual immune cells to attack nerves in multiple sclerosis 4Researchers discover mechanism that limits scar formation 2
(Date:5/4/2015)...  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), ... medical needs in the areas of inflammation, oncology and ... data from three of its biodefense programs at the ... on May 12-14, 2015 to be held at the ... St. Louis MO 63101. ...
(Date:5/4/2015)... , May 4, 2015   Tocagen Inc. ... interim data from Tocagen,s ongoing investigational studies were ... of the American Association of Neurological Surgeons (AANS)/Congress ... May 1-2, 2015, in Washington, D.C. ... held a meeting with FDA and continues to ...
(Date:5/4/2015)... 2015 Marianjoy Rehabilitation Hospital ... arm and hand impairments by acquiring the Armeo®Spring ... Terrace network site. , Secured through grant support ... highly-regarded treatment option for patients with upper extremity ... becomes one of just four Illinois providers offering ...
(Date:5/1/2015)... May 1, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... announced that it has priced an underwritten registered offering ... price of $9.00 per share, and granted the underwriters ... to an additional 585,000 shares of its common stock. ... million.  The offering is expected to close on May 6, ...
Breaking Biology Technology:Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 2Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 3Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 4Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 5Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3
... Calif., March 31 Sigma-Aldrich (Nasdaq: ... high quality services and oligonucleotides to Gene Oracle, an ... the agreement, Sigma-Aldrich will be the exclusive supplier of ... will engage in co-marketing efforts to promote the GeneIOS ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) announced ... the company,s board of directors. Dr. Hutson retired ... in various research and leadership positions with that company, ... Research and Development and director of Pfizer,s pharmaceutical R&D ...
... MYL ) today announced that Matrix Laboratories ... 71.2% controlling interest, has received the first tentative approval ... the President,s Emergency Plan for AIDS Relief (PEPFAR) for ... Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg.Mylan Vice Chairman ...
Cached Biology Technology:Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 2Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 3Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors 2Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors 3Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors 4Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R) 2
... offer you a full range of ... advanced design parameters, effective synthetic siRNA ... you obtain quality results from your ... utilizes their proprietary B-Algo algorithm to ...
... The top-of-the-line PowerPac 3000 power supply ... available, ideal for isoelectric focusing, DNA ... gel electrophoresis, western blotting, and submerged ... W of powre, the PowerPac 3000 ...
... 3000 system, 220-240 V, is used for nucleic ... vertical slab gel format. The system includes the ... of separating nucleic acids with single base-pair resolution ... (IPC and bonded inner glass plate, outer glass ...
The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
Biology Products: